ScreenerHero

VIVSVivoSim Labs Inc. Common Stock

NAS · US · Healthcare · Biotechnology · vivosim.ai
0.2860USD+3.14%Mkt Cap: 3.83M $P/E: —

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap3.83M $
Enterprise Value2.77M $
Revenue (TTM)112.00K $
Gross Profit131.00K $
Net Income (TTM)-13.84M $
Revenue/Share0.0340 USD
Last Price0.2860 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.25
EV/Revenue24.71
P/S33.18
P/B0.16
EPS (TTM)-4.48
EPS (Forward)—
52W Range
0.26900% of range5.300
52W High5.300 USD
52W Low0.2690 USD
Profitability
Gross Margin100.00%
Oper. Margin-15327.78%
EBITDA Margin0.00%
Profit Margin-10567.18%
ROE1259.60%
ROA-187.42%
Growth
Revenue Growth-51.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.83M $
CapEx (TTM)—
FCF Margin-6763.73%
FCF Yield-197.80%
Net Debt-1.35M $
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity-0.41
Current Ratio1.70
Quick Ratio0.90
Book Value/Sh1.703 USD
Cash/Share0.1120 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 19, 2020
Splits
Last Split1:12
Split DateMar 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.39M
Float13.52M
Insiders2.42%
Institutions1.39%
Short Interest
Short Ratio0.1d
Short % Float16.45%
Short % Out.16.33%
Shares Short570.47K
Short (prev mo.)113.91K
Technical
SMA 500.6914 (-58.6%)
SMA 2001.549 (-81.5%)
Beta1.47
S&P 52W Chg18.16%
Avg Vol (30d)11.04M
Avg Vol (10d)11.89M
Technical Indicators
RSI (14)30.0
MACD-0.1146
MACD Signal-0.1318
MACD Hist.+0.0172
BB Upper0.4549 USD
BB Middle0.3580 USD
BB Lower0.2611 USD
BB Width54.15%
ATR (14)0.0709 USD
Vol Ratio (20d)0.09x